France · Investor

Cardinal Partners

Last cheque observed Sep 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment bankWebsite unconfirmed

Series ASeries CSeries BInvestment Banking

Cheques on record
0%of best year0cheques in 12 months, 16 on record
Since the last cheque4050days00hrs00min00sec
Median round$15MRounds led0 of 16Exits1 from the portfolioMostly inUnited States, 100%
Pitch Cardinal Partners

Cardinal Partners highlights

  1. 01

    16 rounds on record

  2. 02

    Mostly Series A and Series C: 56% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Investment bank (from a list, unverified)
Cheque size
Not stated
Sectors
Investment Banking
Based in
Paris, France
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first16 appearances

  1. 2015

    4 rounds

  2. Sept
    lifeIMAGESeries D · US$5.1MWith 4 others
  3. Sept
    IvenixGrowth · US$42MWith 4 others
  4. Jun
    CureatrSeries B · US$13MWith 5 others
  5. May
    lifeIMAGEVenture · US$18MWith 5 others
  6. 2014

    1 round

  7. Sept
    TeladocSeries C · US$50MWith 9 others
  8. 2011

    2 rounds

  9. Nov
    Medley HealthSeries A · US · sec.gov$20MWith 2 others
  10. Sept
    TeladocSeries A · US$18With 4 others
  11. 2009

    1 round

  12. Dec
    TeladocSeries A · US · fis.dowjones.com$9.0MWith 2 others
  13. 2007

    2 rounds

  14. Dec
    AxoGenSeries C · US$12MWith 3 others
  15. Apr
    Bioconnect SystemsSeries A · US$8.0MWith 1 other
  16. 2005

    1 round

  17. Dec
    CardioOpticsSeries B · US$21MWith 4 others
  18. 2004

    1 round

  19. Mar
    Momenta PharmaceuticalsSeries C · US$21MWith 4 others
  20. 2003

    2 rounds

  21. Jul
    Alnylam PharmaceuticalsVenture · US$25MWith 4 others
  22. May
    Momenta PharmaceuticalsSeries B · US$19MWith 3 others
  23. 2002

    2 rounds

  24. Nov
    NexCuraSeries C · US$4.0MWith 2 others
  25. Oct
    CardioOpticsSeries A · US$1.5MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

NexCuraBought by The Thompson CorporationUndisclosedNov 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Cardinal Partners. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Cardinal Partners

What does Cardinal Partners invest in?

Cardinal Partners invests most often at Series A and Series C (56% of the rounds on record), in sectors such as Investment Banking.

How active is Cardinal Partners?

16 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015.

How big are Cardinal Partners's cheques?

The median round it joins is $15M.

Does Cardinal Partners lead rounds?

Rarely, if at all: none of its 16 investments on record names it as the lead.

Where does Cardinal Partners invest?

Most of the companies it backs are in the United States (100%).

Is Cardinal Partners investing now?

No investments in the last 12 months; the latest was in Sept 2015.

Who does Cardinal Partners invest alongside?

Most often Atlas Venture (3 rounds together), HLM Investment Partners (3 rounds together) and Trident Capital (3 rounds together).

What kind of investor is Cardinal Partners?

Cardinal Partners is an investment bank based in Paris, France.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it